CUSIP: 03852X100
Q1 2016 13F Holders as of 31 Mar 2016
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
30,503,087
-
Share change
-
+30,003,952
-
Total reported value
-
$108,281,500
-
Put/Call ratio
-
144%
-
Price per share
-
$3.55
-
Number of holders
-
85
-
Value change
-
+$106,508,997
-
Number of buys
-
85
Quarterly Holders Quick Answers
What is CUSIP 03852X100?
CUSIP 03852X100 identifies ARLZ - ARALEZ PHARMACEUTICALS INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q2 2016
-
Previous quarter:
Q4 2015
Recent filing periods for CUSIP 03852X100:
Institutional Holders of ARALEZ PHARMACEUTICALS INC - COM (ARLZ) as of Q1 2016
As of 31 Mar 2016,
ARALEZ PHARMACEUTICALS INC - COM (ARLZ) was held by
85 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
30,503,087 shares.
The largest 10 holders included
PAR CAPITAL MANAGEMENT INC, Broadfin Capital, LLC, JW Asset Management, LLC, DEERFIELD MANAGEMENT CO, JANUS CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC, Elk Creek Partners, LLC, BlackRock Fund Advisors, Tiger Legatus Capital Management, LLC, and STATE STREET CORP.
This page lists
85
institutional shareholders reporting positions in this security
for the Q1 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.